1 Followers on Owler

Xbrane Bioscience

 develops and commercializes technologies for protein production and vaccine development including lemo and rhamex system products... Read more
OverviewAcquisitionsFundingNews & Insights

Xbrane Bioscience

 develops and commercializes technologies for protein production and vaccine development including lemo and rhamex system products... Read more
Xbrane Bioscience CEO: Martin Åmark

CEO

Martin Åmark

CEO Approval Rating

70/100

2008

PublicIndependent CompanyNasdaq OMX NordicXBRANE

Professional Services
- -

Annual Revenue
$20.5M
Employees
38
Funding
$15.2M
Acquisitions
1

News

Leadership Change
Jan 10, 2025
Marketscreener
Jane Benyamin joined Xbrane Bioscience as Chief Financial Officer

Trending Companies